Annual CFF
$8.16 M
+$4.47 M+120.92%
December 31, 2023
Summary
- As of February 7, 2025, ACXP annual cash flow from financing activities is $8.16 million, with the most recent change of +$4.47 million (+120.92%) on December 31, 2023.
- During the last 3 years, ACXP annual CFF has risen by +$4.12 million (+101.88%).
- ACXP annual CFF is now -44.83% below its all-time high of $14.80 million, reached on December 31, 2021.
Performance
ACXP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.59 M
+$1.27 M+397.03%
September 30, 2024
Summary
- As of February 7, 2025, ACXP quarterly cash flow from financing activities is $1.59 million, with the most recent change of +$1.27 million (+397.03%) on September 30, 2024.
- Over the past year, ACXP quarterly CFF has increased by +$1.59 million (+100.00%).
- ACXP quarterly CFF is now -89.24% below its all-time high of $14.80 million, reached on June 30, 2021.
Performance
ACXP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$11.04 M
+$1.59 M+16.84%
September 30, 2024
Summary
- As of February 7, 2025, ACXP TTM cash flow from financing activities is $11.04 million, with the most recent change of +$1.59 million (+16.84%) on September 30, 2024.
- Over the past year, ACXP TTM CFF has increased by +$7.50 million (+211.57%).
- ACXP TTM CFF is now -37.68% below its all-time high of $17.72 million, reached on June 30, 2021.
Performance
ACXP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ACXP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +120.9% | +100.0% | +211.6% |
| 3 y3 years | +101.9% | -55.1% | +52.5% |
| 5 y5 years | +83.2% | -55.1% | +52.5% |
ACXP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.8% | +120.9% | -65.5% | -100.0% | -25.4% | -100.0% |
| 5 y | 5-year | -44.8% | +120.9% | -89.2% | -100.0% | -37.7% | -100.0% |
| alltime | all time | -44.8% | +120.9% | -89.2% | -100.0% | -37.7% | -100.0% |
Acurx Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.59 M(+397.0%) | $11.04 M(+16.8%) |
| Jun 2024 | - | $320.20 K(-92.9%) | $9.45 M(-25.4%) |
| Mar 2024 | - | $4.51 M(-2.4%) | $12.67 M(+55.2%) |
| Dec 2023 | $8.16 M(+120.9%) | $4.62 M(>+9900.0%) | $8.16 M(+130.4%) |
| Sep 2023 | - | $0.00(-100.0%) | $3.54 M(-51.0%) |
| Jun 2023 | - | $3.54 M(>+9900.0%) | $7.24 M(+95.9%) |
| Mar 2023 | - | $0.00(0.0%) | $3.70 M(0.0%) |
| Dec 2022 | $3.70 M | $0.00(-100.0%) | $3.70 M(0.0%) |
| Sep 2022 | - | $3.70 M(>+9900.0%) | $3.70 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $14.80 M(+265.9%) | $0.00(0.0%) | $14.80 M(-4.7%) |
| Sep 2021 | - | $0.00(-100.0%) | $15.53 M(-12.4%) |
| Jun 2021 | - | $14.80 M(+1931.2%) | $17.72 M(+338.1%) |
| Dec 2020 | $4.04 M(-9.2%) | $728.50 K(-66.7%) | $4.04 M(+22.0%) |
| Sep 2020 | - | $2.19 M(+94.9%) | $3.32 M(+194.9%) |
| Jun 2020 | - | $1.12 M(>+9900.0%) | $1.12 M(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $4.46 M | - | - |
FAQ
- What is Acurx Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual CFF year-on-year change?
- What is Acurx Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly CFF year-on-year change?
- What is Acurx Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals TTM CFF year-on-year change?
What is Acurx Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ACXP is $8.16 M
What is the all time high annual CFF for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual cash flow from financing activities is $14.80 M
What is Acurx Pharmaceuticals annual CFF year-on-year change?
Over the past year, ACXP annual cash flow from financing activities has changed by +$4.47 M (+120.92%)
What is Acurx Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ACXP is $1.59 M
What is the all time high quarterly CFF for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly cash flow from financing activities is $14.80 M
What is Acurx Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ACXP quarterly cash flow from financing activities has changed by +$1.59 M (+100.00%)
What is Acurx Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ACXP is $11.04 M
What is the all time high TTM CFF for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high TTM cash flow from financing activities is $17.72 M
What is Acurx Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ACXP TTM cash flow from financing activities has changed by +$7.50 M (+211.57%)